We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

A new multiplex PCR test gains CE-IVDR marking, enabling rapid single-sample detection of 13 respiratory pathogens. More...
11 Nov 2026
Image Credit: Adobe Stock

AI Tool Automates Variant Curation and Interpretation for Cancer Whole-Genome Sequencing

Inocras is presenting the first public results from its multimodal agentic AI framework at the AMP 2026 Annual Meeting & Expo. More...
11 Nov 2026
Image: Figure 1 from Lim J, et al. “Amplification of RNA for Identification of Zika and HCV in Whole Blood.” Science Advances, 2026. https://doi.org/10.1126/sciadv.aeb6129. Licensed under CC BY-NC 4.0. Created in BioRender: https://BioRender.com/mr4p5qy.

Portable Test Detects Zika and Hepatitis C RNA from Whole Blood

A new test detects Zika and HCV RNA directly from whole blood at point of care in hours without lab equipment. More...
11 Nov 2026
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

bioMérieux has received FDA 510(k) clearance and IVDR CE marking for VITEK PRO, its new automated microbial ID/AST system. More...
11 Nov 2026
Image: The findings help explain why patients with rheumatoid arthritis respond differently to treatment and support development of Aqtual’s blood-based test for selecting among TNF inhibitors, JAK inhibitors, and abatacept (Image Credit: Adobe Stock)

Blood-Based Test May Predict Response Across Rheumatoid Arthritis Drug Classes

A blood-based tumor DNA test predicts response to multiple rheumatoid arthritis therapies. More...
11 Nov 2026
Image Credit: Adobe Stock

Early Blood Test Patterns Linked to Three-Year Kidney Transplant Outcomes

New data link early dd-cfDNA trajectories to 3-year kidney allograft loss and rejection, distinguishing transient rises. More...
11 Nov 2026
Image: Overview of study. CeVD, cerebrovascular disease; MACCE, major adverse cardiovascular or cerebrovascular events. (Photo courtesy of NUS Yong Loo Lin School of Medicine)

Blood Protein Signatures May Predict Brain Vessel Damage and Cognitive Decline

Researchers identify four blood proteins that flag risk of cerebrovascular disease, cognitive decline, and cardiovascular events More...
10 Nov 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Platelet Function Analyzer
PL-12